| Literature DB >> 26062607 |
Luís Leite1, Rui Baptista2, Jorge Leitão3, Joana Cochicho4, Filipe Breda5, Luís Elvas6, Isabel Fonseca7, Armando Carvalho8, José Nascimento Costa9.
Abstract
BACKGROUND: Fast and accurate chest pain risk stratification in the emergency department (ED) is critical. The HEART score predicts the short-term incidence of major adverse cardiac events (MACE) in this population, dividing it in three risk categories. We aimed to describe the population with chest pain, to characterize the subgroup of patients with acute coronary syndrome (ACS) and to assess the prognostic value of Manchester triage system and of HEART score.Entities:
Mesh:
Year: 2015 PMID: 26062607 PMCID: PMC4462114 DOI: 10.1186/s12872-015-0049-6
Source DB: PubMed Journal: BMC Cardiovasc Disord ISSN: 1471-2261 Impact factor: 2.298
Demographic characteristics and Manchester triage system
| Variable | |
|---|---|
| Age, mean ± SD | 57.7 ± 19 |
| Male gender, n (%) | 129 (55.4) |
| Manchester triage system, n (%) | |
| - Red | 1 (0.4) |
| - Orange | 102 (43.8) |
| - Yellow | 99 (42.5) |
| - Green | 31 (13.3) |
| Past medical history, n (%) | |
| - Hypertension | 125 (53.6) |
| - Dyslipidemia | 90 (38.6) |
| - Type 2 diabetes | 33 (14.2) |
| - Active smoker | 31 (13.3) |
| - Coronary artery disease | 36 (15.5) |
| - Atrial fibrillation | 42 (18) |
| - Heart failure | 38 (16.3) |
| - Chronic pulmonary obstructive disease | 16 (6.9) |
| - Chronic kidney disease | 11 (4.7) |
| - Others | 31 (13.3) |
SD standard deviation
Figure 1Final diagnosis of patients. COPD, chronic obstructive pulmonary disease
Figure 2Flow diagram of patients presenting with chest pain. ED, emergency department; ACS, acute coronary syndrome; MACE, major adverse cardiovascular events
Comparative of population characteristics ACS versus no ACS
| Group 1 – ACS ( | Group 2 – No ACS ( |
| |
|---|---|---|---|
| Age, mean ± SD | 65.6 ± 15 | 56.9 ± 19 | 0.043 |
| Male gender, n (%) | 18 (81.8) | 111 (52.6) | 0.012 |
| Hypertension, n (%) | 18 (81.8) | 107 (50.7) | 0.006 |
| Dyslipidemia, n (%) | 17 (73.9) | 73 (34.6) | 0.001 |
| Type 2 diabetes, n (%) | 8 (36.4) | 25 (11.8) | 0.005 |
| Smoking, n (%) | 8 (36.4) | 23 (10.9) | 0.003 |
| Coronary artery disease, n (%) | 9 (40.9) | 27 (12.7) | 0.002 |
| Atrial fibrillation, n (%) | 3 (13.6) | 39 (18.5) | 0.773 |
| Heart failure, n (%) | 3 (13.6) | 35 (16.6) | 0.957 |
| Chronic pulmonary obstructive disease, n (%) | 1 (4.5) | 16 (7.6) | 0.376 |
| Chronic kidney disease, n (%) | 5 (22.7) | 6 (2.8) | 0.002 |
ACS acute coronary syndrome, SD standard deviation
Figure 3Incidence of 6-week MACE in each HEART score. MACE, major adverse cardiovascular events
Figure 4Incidence 6-week MACE in each HEART score risk category. MACE, major adverse cardiovascular events
Sensitivity, specificity, positive and negative predictive values for six-week incidence of MACE using HEART score
| Cut-off = 4a | Cut-off = 7b | |
|---|---|---|
| Sensitivity, % [95 % CI] | 90.9 [70.8; 98.9] | 45.5 [24.4; 67.79] |
| Specificity, % [95 % CI] | 63.2 [55.0; 70.8] | 98.7 [95.3; 99.8] |
| Positive predictive value, % [95 % CI] | 26.3 [16.9; 37.7] | 83.3 [51.59; 97.9] |
| Negative predictive value, % [95 % CI] | 97.9 [92.8; 99.8] | 92.6 [87.4; 96.1] |
a98 patients with score <4 and 76 with score ≥4
b162 patients with score <7 and 12 with score ≥7